Next 10 |
home / stock / clabf / clabf news
2023-12-11 04:21:42 ET More on Core One Labs Inc. Financial information for Core One Labs Inc. For further details see: Core One Labs signs initial agreement for potential sale of proprietary biosynthetic psilocybin
VANCOUVER, BC / ACCESSWIRE / December 8, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce the signing of an Initial Agreement (the " Agreement ") with Cube Psytech Corp. (" Cube Psytech ") marking a sig...
VANCOUVER, BC / ACCESSWIRE / December 1, 2023 / Core One Labs Inc. (" Core One " or the " Company ") (CNSX: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN: A3CSSU ), an emerging leader in the field of neuroscience and psychedelics, is delighted to share the exciting results of its first round of S...
VANCOUVER, BC / ACCESSWIRE / August 4, 2023 / Core One Labs Inc. (CSE: COOL ) (OTCQB: CLABF ) (Frankfurt: LD6 , WKN:A3CSSU), (the " Company " or " Core One ") is delighted to announce the receipt of additional positive results from its second round (" Round 2 ") of Stage 1 animal model studies. ...
Core One's Wholly-Owned Subsidiary has filed a patent application with the United States Patent and Trademark Office VANCOUVER, BC / ACCESSWIRE / August 1, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 , WKN:A3CSSU) (the " Company " or " Core One ") proudly announces a...
VANCOUVER, BC / ACCESSWIRE / July 28, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6) (WKN:A3CSSU) (the " Company " or " Core One "), is excited to share positive results from its first round of Stage 1 animal model studies (" Round 1"), conducted by its research partners...
VANCOUVER, BC / ACCESSWIRE / July 21, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN: A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly-owned subsidiary, GMP Drug Inc. (" GMP Drug "), has entered into a non-binding letter of intent ...
VANCOUVER, BC / ACCESSWIRE / July 11, 2023 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU ) (the " Company ") is pleased to announce that its wholly-owned subsidiary Vocan Biotechnologies Inc. (" Vocan ") has incorporated a state-of-the-art, high density, fer...
VANCOUVER, BC / ACCESSWIRE / July 7, 2023 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 ), (WKN: A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly owned subsidiary, Vocan Biotechnologies Inc. (" Vocan "), has completed final steps of its r...
VANCOUVER, BC / ACCESSWIRE / November 18, 2022 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 , WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce the initial production run of its psilocybin active pharmaceutical ingredient (API) product at a good ma...
News, Short Squeeze, Breakout and More Instantly...
Core One Labs Inc. Company Name:
CLABF Stock Symbol:
OTCMKTS Market:
VANCOUVER, BC / ACCESSWIRE / December 8, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce the signing of an Initial Agreement (the " Agreement ") with Cube Psytech Corp. (" Cube Psytech ") marking a sig...
VANCOUVER, BC / ACCESSWIRE / December 1, 2023 / Core One Labs Inc. (" Core One " or the " Company ") (CNSX: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN: A3CSSU ), an emerging leader in the field of neuroscience and psychedelics, is delighted to share the exciting results of its first round of S...
VANCOUVER, BC / ACCESSWIRE / August 4, 2023 / Core One Labs Inc. (CSE: COOL ) (OTCQB: CLABF ) (Frankfurt: LD6 , WKN:A3CSSU), (the " Company " or " Core One ") is delighted to announce the receipt of additional positive results from its second round (" Round 2 ") of Stage 1 animal model studies. ...